Adeza to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
03 Noviembre 2005 - 3:00AM
Business Wire
Adeza (NASDAQ: ADZA) today announced that Mark Fischer-Colbrie,
chief financial officer, will make an investment community
presentation at the Rodman & Renshaw Techvest 7th Annual
Healthcare Conference on Wednesday, November 9, at 11:15 a.m.
Eastern Time (8:15 a.m. Pacific Time). The conference is being held
at the Palace Hotel in New York City. A live audio webcast and
slide presentation will be available via the Internet by visiting
the "Investors" section of the company's Web site at www.adeza.com.
An archived presentation will be available on the Web site for 14
days. About Adeza Adeza designs, manufactures and markets
innovative products for women's health. Adeza's initial focus is on
reproductive healthcare, using its proprietary technologies to
predict preterm birth and assess infertility. Adeza's principal
product is a patented diagnostic test, FullTerm(R), The Fetal
Fibronectin Test, which utilizes a single-use, disposable cassette
and is analyzed on Adeza's patented TLiIQ(R) System. This product
is approved by the U.S. Food and Drug Administration (FDA) for use
in assessing the risk of preterm birth. Adeza also markets and
sells the E-tegrity(R) Test, an infertility-related test to assess
receptivity of the uterus to embryo implantation in women with
unexplained infertility. More information is available at
www.adeza.com. Adeza cautions you that statements included in this
press release that are not a description of historical facts may be
forward-looking statements. The inclusion of forward-looking
statements should not be regarded as a representation by Adeza that
any of its plans will be achieved. Actual results may differ
materially from those set forth in this release due to the risks
and uncertainties inherent in Adeza's business including, without
limitation, statements about the expansion of the indications for
its products. All forward-looking statements are qualified in their
entirety by this cautionary statement and Adeza undertakes no
obligation to revise or update this news release to reflect events
or circumstances after the date hereof.
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adeza Biomedical (MM) (NASDAQ): 0 recent articles
Más de Adeza Artículos de Noticias